# Short-course Antimicrobial Therapy in Sepsis

> **NCT02899143** · PHASE2 · UNKNOWN · sponsor: **Ospedale Santa Maria delle Croci** · enrollment: 320 (estimated)

## Conditions studied

- Infection
- Sepsis
- Severe Sepsis
- Septic Shock

## Interventions

- **DRUG:** Antibiotic

## Key facts

- **NCT ID:** NCT02899143
- **Lead sponsor:** Ospedale Santa Maria delle Croci
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899143, "Short-course Antimicrobial Therapy in Sepsis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02899143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
